SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001628280-24-018983
Filing Date
2024-04-29
Accepted
2024-04-29 16:05:14
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A a2024proxycardnotice.htm DEFA14A 4717
2 a2024proxycardnotice001.jpg GRAPHIC 94761
3 a2024proxycardnotice002.jpg GRAPHIC 158080
4 a2024proxycardnotice003.jpg GRAPHIC 108539
  Complete submission text file 0001628280-24-018983.txt   503590
Mailing Address 21 ERIE ST. CAMBRIDGE MA 02139
Business Address 21 ERIE ST. CAMBRIDGE MA 02139 617-465-0013
Prime Medicine, Inc. (Filer) CIK: 0001894562 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-41536 | Film No.: 24890574
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)